Table 2. Laboratory results and characteristics of 15 mumps patients with specimens for molecular detection.
Patient | Age (in years) | Days between symptom onset and sample collection | ELISA results | Real-time PCR | Vaccination status |
---|---|---|---|---|---|
20 | 21 | 1 | IgM-, IgG+ | positive | two doses |
21 | 20 | 2 | IgM-, IgG+ | positive | one dose |
22 | 21 | 2 | IgM-, IgG+ | positive | unknown |
23 | 21 | 2 | IgM-, IgG+ | positive | unknown |
24 | 28 | 3 | IgM-, IgG+ | negative | two doses |
25 | 22 | 4 | IgM-, IgG+ | negative | two doses |
26 | 21 | 2 | IgM-, IgG+ | positive | two doses |
27 | 4 | 3 | IgM-, IgG+ | negative | unknown |
28 | 20 | no data | IgM-, IgG+ | negative | two doses |
29 | 25 | 3 | IgM-, IgG+ | positive | unvaccinated |
30 | 21 | no data | IgM-, IgG ev a | negative | unknown |
31 | 32 | no data | not done | negative | unknown |
32 | 7 | 2 | IgM-, IgG+ | positive | two doses |
33 | 21 | 2 | IgM-, IgG+ | positive | two doses |
34 | 22 | 3 | not done | positive | one dose |
a equivocal